Plenary session 1: Challenges and achievements in disease eradication
Session chair: Tony Fooks
Animal and Plant Health Agency, UK
The session will focus on the challenges and achievements in vaccinology emphasizing the eradication of infectious diseases to achieve the United Nations Sustainable Development Goals, with a specific focus on ending global poverty.
In the 20th century, vaccines were developed leading to the elimination of many life-threatening childhood diseases. In 1980, the WHO declared that smallpox in humans had been eradicated, leading to discontinuation of the worldwide vaccination campaign. This was followed in 2011 with both the UN Food and Agriculture Organization and the World Organization for Animal Health declaring global eradication of rinderpest for cattle.
In the 21st century, the exploitation of new technologies within a regulatory framework for the rapid development and deployment of cost-effective, safe and efficacious vaccines is clearly required, especially to combat ancient, new and emerging diseases.
Emeritus Professor of the University of Pennsylvania, and Adjunct Professor of the Johns Hopkins University, USA
At least ten candidate vaccines are being developed against the human cytomegalovirus (CMV) because it is the most important worldwide cause of congenital abnormalities and complications of transplantation.
However, the biology of CMV is complex and so is vaccine development. A new vaccine against zoster, the recrudescence of varicella virus, has been licensed and shows high efficacy.
Plenary session 3: Delivering vaccines – why is it difficult and what are the solutions?
Session Chair: Gregory A. Poland, Editor in Chief,
Vaccine and Mayo Clinic, USA
The Plenary Session on Delivering Vaccines – Why It Is Difficult and What Are The Solutions – will be chaired by Dr. Greg Poland, the Editor-in-Chief of the journal Vaccine. He will speak on “A 12-Step Program to Improving Vaccine Delivery in the 21st Century”, followed by Dr. Dan Salmon from Johns Hopkins University who will speak from his perspective as a former lead in the US National Vaccine Program Office on “Vaccines Don’t Save Lives – Vaccinations Do”.
Breakout session 1: Vaccine safety science
Session Chair: Bob Chen
Centers for Disease Control and Prevention, USA
Breakout Session 1 on Vaccine Safety Science will focus on the latest developments to develop a platform for rigorous vaccine safety studies in Europe similar to the Vaccine Safety Datalink (VSD) and PRISM platforms in the U.S.
Professor Miriam Sturkenboom, Julius Global Health University Medical Center, The Netherlands will speak on “The ADVANCE system for monitoring benefits and risks of vaccines in EU.”
Breakout session 8: Vaccines against mosquito and tick-borne diseases
Session Chair: Jose de la Fuente,
SaBio. Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Spain and Oklahoma State University, USA
Vector-borne infections are transmitted from an infected and infectious vertebrate host to another via intermediary hematophagous arthropods. Mosquitoes are the most important vectors of human pathogens, and ticks are economically important ectoparasites of domestic and wild animals, and are considered to be second worldwide to mosquitoes as vectors of human pathogens.
The incidence of vector-borne diseases is a growing burden worldwide accounting for over 20% of emerging infectious diseases recorded during 1940-2004.Vaccines appear as the most effective and environmentally sound intervention for the prevention and control of these diseases.
This session will discuss recent advances in the characterization of vector-host-pathogen interactions and development of bioinspired vaccines for the control of major vector-borne diseases such as tick-borne diseases, Malaria, Zika, Yellow fiver, Ebola and Lassa fever.